Insiders · NGNE

Robert Baffi

Director at Neurogene Inc. (NGNE) since December 2023

Robert Baffi has filed 5 insider reports with the SEC since December 2023, as director at Neurogene Inc. (NGNE). The latest filing, on February 24, 2026, reports grant or award at Neurogene Inc. (NGNE).

Filings
5
Companies
1
Bought on market
None
Sold on market
None

Companies where Robert Baffi is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Neurogene Inc. logo
NGNE
Neurogene Inc.
Directorsince December 2023$22.15Feb 24, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert Baffi with

Other insiders at the same companies

Questions about Robert Baffi

What is Robert Baffi's role at Neurogene Inc.?
Robert Baffi reports to the SEC as director at Neurogene Inc. (NGNE), according to the latest filing on February 24, 2026.
Has Robert Baffi bought or sold stock recently?
No open-market purchases or sales by Robert Baffi are on file. The filings report grant or award.
How do I get alerts when Robert Baffi files?
Follow Robert Baffi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert Baffi (SEC CIK 0001274826). Totals count each trade once, skipping amendments whose original is on file, from Dec 26, 2023 on. View on SEC EDGAR · Get this as JSON